Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-25-059798
Filing Date
2025-06-30
Accepted
2025-06-30 17:34:53
Documents
1
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 6874
  Complete submission text file 0001213900-25-059798.txt   8520
Mailing Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
STEINMAN LAWRENCE (Reporting) CIK: 0001132679 (see all company filings)

State of Incorp.: DE
Type: 4/A | Act: 34 | File No.: 001-38105 | Film No.: 251093457

Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)